A cadre of new scientists is needed to offer novel perspectives and innovative approaches to HIV and substance use research. Previous research has documented the limited numbers of underrepresented ethnically diverse and other underrepresented researchers addressing the HIV pandemic through research careers.[1,2] Pilot studies represent an important opportunity to not only increase the involvement of underrepresented groups of scientific investigators pursuing new research initiatives, but to provide mentoring opportunities critical to the success of emerging scholars. Specifically, pilot projects create opportunities for the further training and career development of new investigators by promoting collaboration with established senior colleagues of the Center. The opportunity for new HIV investigators to gain guidance and support is critical for continued scientific progress towards addressing the HIV epidemic and the role of substance use. The proposed Pilot Projects and Mentoring (PPM) Core will foster opportunities for mentorship and support for new or early stage investigators (those within 10 years of doctoral studies completion) by drawing on a conceptually-driven framework based on the empirical literature on mentoring. The proposed Core, provides short-term support for investigators targeting new research initiatives or testing the feasibility of new research strategies with the goal of obtaining subsequent extramural funding. The overall goal of the PPM is to promote pilot testing of innovative areas of research in the field of HIV and substance use that require preliminary data for subsequent extramural funding.
The specific aims are:
Aim 1. To solicit and review pilot project proposals;
Aim 2. To ensure mentoring and further training of investigators receiving pilot funds and other new or early stage investigators. The PPM Core seeks to support research conducted by the following 4 groups of investigators: 1. New or early stage investigators; 2. Established investigators without prior experience in the field of substance use and HIV research; 3. Established HIV investigators pursuing a new area of inquiry within the field of substance use and HIV research;and ' 4. Established substance use investigators pursuing new research related to HIV. For all of the above categories we will prioritize and support specific groups determined by NIH and NIDA to be nationally underrepresented in the field of HIV and substance use research (PA-08-190, http://grants.nih.gov/grants/guide/pa-files/pa-08-190.html). RFAs will be developed and advertised at the 4 CDUHR-affiliated institutions (NYU, NDRI, BIMC and JJCCJ). Underrepresented groups of new and early stage investigators will be prioritized in the RFA evaluation criteria. A multi-component mentoring structure, based on previous research, will be implemented to support the development of new and early stage investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Center Core Grants (P30)
Project #
5P30DA011041-17
Application #
8650803
Study Section
Special Emphasis Panel (ZDA1-EXL-T)
Project Start
Project End
Budget Start
2014-01-01
Budget End
2014-12-31
Support Year
17
Fiscal Year
2014
Total Cost
$195,098
Indirect Cost
$54,899
Name
New York University
Department
Type
DUNS #
041968306
City
New York
State
NY
Country
United States
Zip Code
10012
Smith, Daniel J; Neurer, Josh; Jordan, Ashly E et al. (2017) Epidemiology of Hepatitis C Virus Among People Who Inject Drugs: Protocol for a Systematic Review and Meta-Analysis. JMIR Res Protoc 6:e201
Wiessing, Lucas; Ferri, Marica; B?lá?ková, Vendula et al. (2017) Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study. Harm Reduct J 14:19
Ritchie, Amanda; Gwadz, Marya Viorst; Perlman, David et al. (2017) Eliminating Racial/Ethnic Disparities in AIDS Clinical Trials in the United States: A Qualitative Exploration of an Efficacious Social/Behavioral Intervention. J AIDS Clin Res 8:
Nikolopoulos, G K; Katsoulidou, A; Kantzanou, M et al. (2017) Evaluation of the limiting antigen avidity EIA (LAg) in people who inject drugs in Greece. Epidemiol Infect 145:401-412
Aronson, Ian David; Guarino, Honoria; Bennett, Alexander S et al. (2017) Staff Perspectives on a Tablet-Based Intervention to Increase HIV Testing in a High Volume, Urban Emergency Department. Front Public Health 5:170
Freeman, Robert; Gwadz, Marya Viorst; Silverman, Elizabeth et al. (2017) Critical race theory as a tool for understanding poor engagement along the HIV care continuum among African American/Black and Hispanic persons living with HIV in the United States: a qualitative exploration. Int J Equity Health 16:54
Palamar, Joseph J; Acosta, Patricia; Calderón, Fermín Fernández et al. (2017) Assessing self-reported use of new psychoactive substances: The impact of gate questions. Am J Drug Alcohol Abuse 43:609-617
Palamar, Joseph J; Shearston, Jenni; Cleland, Chuck (2017) Discordant reporting of nonmedical opioid use: reply to letter to the editor. Am J Drug Alcohol Abuse 43:125-126
Jordan, Ashly E; Perlman, David C; Reed, Jennifer et al. (2017) Patterns and Gaps Identified in a Systematic Review of the Hepatitis C Virus Care Continuum in Studies among People Who Use Drugs. Front Public Health 5:348
Perlman, David C; Jordan, Ashly E (2017) Considerations for the Development of a Substance-Related Care and Prevention Continuum Model. Front Public Health 5:180

Showing the most recent 10 out of 249 publications